.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Chinese Patent Office
US Army
AstraZeneca
Queensland Health
Fish and Richardson
Deloitte
Citi
Harvard Business School

Generated: November 19, 2017

DrugPatentWatch Database Preview

Labetalol hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for labetalol hydrochloride and what is the scope of labetalol hydrochloride patent protection?

Labetalol hydrochloride
is the generic ingredient in three branded drugs marketed by West-ward Pharms Int, Par Form, Sandoz, Innogenix, Cnty Line Pharms, Apothecon, Akorn Inc, Sebela Ireland Ltd, Watson Labs, Sagent Agila Llc, Hospira, Zydus Pharms Usa Inc, Baxter Hlthcare Corp, Schering, Ivax Sub Teva Pharms, Teva, and Gland Pharma Ltd, and is included in twenty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for labetalol hydrochloride. Thirty-two suppliers are listed for this compound. There is one tentative approval for this compound.

Pharmacology for labetalol hydrochloride

Medical Subject Heading (MeSH) Categories for labetalol hydrochloride

Tentative approvals for LABETALOL HYDROCHLORIDE

Applicant Application No. Strength Dosage Form
u► Subscribe5MG/MLINJECTABLE;INJECTION
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
LABETALOL HYDROCHLORIDE
labetalol hydrochloride
TABLET;ORAL075133-001Aug 3, 1998ABRXNoNo► Subscribe► Subscribe► Subscribe
Cnty Line Pharms
TRANDATE
labetalol hydrochloride
TABLET;ORAL018716-002Aug 1, 1984ABRXNoNo► Subscribe► Subscribe► Subscribe
Par Form
LABETALOL HYDROCHLORIDE
labetalol hydrochloride
TABLET;ORAL200908-003Jul 10, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva
LABETALOL HYDROCHLORIDE
labetalol hydrochloride
TABLET;ORAL074989-002Sep 30, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva
LABETALOL HYDROCHLORIDE
labetalol hydrochloride
TABLET;ORAL074989-003Sep 30, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva
LABETALOL HYDROCHLORIDE
labetalol hydrochloride
TABLET;ORAL074989-001Sep 30, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
Akorn Inc
LABETALOL HYDROCHLORIDE
labetalol hydrochloride
INJECTABLE;INJECTION075524-001Nov 29, 1999APRXNoNo► Subscribe► Subscribe► Subscribe
Sagent Agila Llc
LABETALOL HYDROCHLORIDE
labetalol hydrochloride
INJECTABLE;INJECTION079134-001Feb 3, 2010APRXNoNo► Subscribe► Subscribe► Subscribe
Sebela Ireland Ltd
TRANDATE
labetalol hydrochloride
INJECTABLE;INJECTION019425-001Dec 31, 1985DISCNYesNo► Subscribe► Subscribe► Subscribe
Hospira
LABETALOL HYDROCHLORIDE
labetalol hydrochloride
INJECTABLE;INJECTION075242-001Sep 30, 1999DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
Fuji
Mallinckrodt
US Army
AstraZeneca
Queensland Health
Chinese Patent Office
Dow
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot